Sterling Biotech and Zydus Lifesciences agree to extend completion of business transfer
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
This facility marks a significant milestone in transforming the global food industr
New research labs and process development services to enable next generation therapeutics
Partnership to Combine AbbVie's Oncology Expertise with EvolveImmune's Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India with support from Sonnet and enable global and India regulatory filings
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
This approval reflects company’s unwavering commitment that the quality assurance
Fermenta Biotech’s API manufacturing facility receives EU GMP compliance certificate
Subscribe To Our Newsletter & Stay Updated